The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Neuroleptic malignant syndrome
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuroleptic malignant syndrome
(1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.10.1137 · Cited by 978
The neuroleptic malignant syndrome
(1980) · Reactions · doi:10.1007/bf03264026 · Cited by 460
A PROTOCOL FOR THE INVESTIGATION OF MALIGNANT HYPERPYREXIA (MH) SUSCEPTIBILITY
(1984) · British Journal of Anaesthesia · doi:10.1093/bja/56.11.1267 · Cited by 439
Neuroleptic malignant syndrome: A pathogenetic role for dopamine receptor blockade?
Henderson, V. W., & Wooten, G. F. (1981) · Neurology · doi:10.1212/wnl.31.2.132 · Cited by 339
Neuroleptic Malignant Syndrome
Guzé, B. H., & Baxter, L. R. (1985) · New England Journal of Medicine · doi:10.1056/nejm198507183130306 · Cited by 312
Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.10.1227 · Cited by 302
Mortality from neuroleptic malignant syndrome.
Shalev, A. Y., Hermesh, H., & Munitz, H. (1989) · PubMed · Cited by 290
The neuroleptic malignant syndrome: agent and host interaction
Shalev, A., & Munitz, H. (1986) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1986.tb02694.x · Cited by 261
Sympathoadrenal Hyperactivity and the Etiology of Neuroleptic Malignant Syndrome
Gurrera, R. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.2.169 · Cited by 214
Neuroleptic Malignant Syndrome-like State Following a Withdrawal of Antiparkinsonian Drugs
TORU, M., MATSUDA, O., MAKIGUCHI, K., & SUGANO, K. (1981) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198105000-00011 · Cited by 213
Neuroleptic malignant syndrome. Review of response to therapy
Rosenberg, M. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.9.1927 · Cited by 185
Neuroleptic Malignant Syndrome
Rosenberg, M. R. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390090009002 · Cited by 176
Burke, R. E., Fahn, S., Mayeux, R., Weinberg, H., Louis, K., & Willner, J. H. (1981) · Neurology · doi:10.1212/wnl.31.8.1022 · Cited by 171
Clinical and pharmacologic risk factors for neuroleptic malignant syndrome: a case–control study
Berardi, D., Amore, M., Keck, P. E., Troia, M., & Dell’Atti, M. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00530-1 · Cited by 150
Dopamine receptors in the central thermoregulatory pathways of the rat.
Cox, B., Kerwin, R. W., & Tf, L. (1978) · The Journal of Physiology · doi:10.1113/jphysiol.1978.sp012476 · Cited by 126
A case of neuroleptic malignant syndrome successfully treated with amantadine.
Mm, M., Ml, B., & Jj, P. (1982) · PubMed · Cited by 102
Case-control study of neuroleptic malignant syndrome
Sachdev, P. S., Mason, C., & Hadži-Pavlović, D. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.8.1156 · Cited by 98
A prospective survey of neuroleptic malignant syndrome in a short-term psychiatric hospital
Gelenberg, A. J., Bellinghausen, B., Wojcik, J., et al. (1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.4.517 · Cited by 94
Declining frequency of neuroleptic malignant syndrome in a hospital population
Keck, P. E., Pope, H. G., & McElroy, S. L. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.7.880 · Cited by 81
The neuroleptic malignant syndrome and its differentiation from lethal catatonia
Fleischhacker, W. W., Sperner‐Unterweger, B., Kane, J. M., & Hinterhuber, H. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb06439.x · Cited by 67
Rhabdomyolysis and malignant hyperpyrexia.
Denborough, M. A., Collins, S. P., & Hopkinson, K. C. (1984) · BMJ · doi:10.1136/bmj.288.6434.1878 · Cited by 59
Neuroleptic malignant syndrome
Araki, M., Takagi, A., Higuchi, I., et al. (1988) · Neurology · doi:10.1212/wnl.38.2.297 · Cited by 39
Porcine malignant hyperthermia: Cell injury enhances halothane sensitivity of biopsies
Gallant, E. M., Fletcher, T. F., Goettl, V. M., & Rempel, W. E. (1986) · Muscle & Nerve · doi:10.1002/mus.880090211 · Cited by 35
Kawanishi, C., Hanihara, T., Shimoda, Y., Suzuki, K., Sugiyama, N., Onishi, H., Miyakawa, T., Yamada, Y., & Kosaka, K. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.9.1275 · Cited by 27
Differentiating Neuroleptic-Related Heatstroke From Neuroleptic Malignant Syndrome
Lazarus, A. L. (1989) · Psychosomatics · doi:10.1016/s0033-3182(89)72256-8 · Cited by 24
Acute Hypernatremia and Neuroleptic Malignant Syndrome in Parkinson Disease
Cao, L., & Katz, R. H. (1999) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40575-0 · Cited by 13
Cited by
Girard, T. D., Pandharipande, P. P., Carson, S. S., Schmidt, G. A., Wright, P. E., Canonico, A. E., Pun, B. T., Thompson, J. L., Shintani, A. K., Meltzer, H. Y., et al. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181c58715 · Cited by 451
Recurrent Heat-Related Illnesses During Antipsychotic Treatment
Kwok, J. S., & Chan, T. Y. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1g130 · Cited by 45
Metadata
- Authors
- Adnet, P., Lestavel, P., & Krivosic-Horber, R.
- Venue
- British Journal of Anaesthesia
- Publisher
- Elsevier BV
- Published
- 2000-07
- Volume
- 85
- Issue
- 1
- Pages
- 129-135
- ISSN
- 0007-0912 (ISSN-L)
- OpenAlex
- W2105070570
- Cited by
- 278
- References
- 26
- FWCI
- 4.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.